[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Insider transactions by Vita Coco Company, Inc. (COCO) show the chief operating officer engaged in a planned sale of 3,173 shares of common stock under a Rule 10b5-1 trading plan at $42.50 per share, which reduced his direct holdings from 79,300 to 76,127 shares. The filing also reports the grant and continued ownership of multiple non-qualified stock options with exercise prices ranging from $10.178 to $33.36, some fully vested and exercisable and others subject to multi-year vesting schedules. The disclosure records routine option grants and an executed plan-based sale, providing transparency about executive equity and compensation.

Positive

• Sale executed under a Rule 10b5-1 trading plan providing pre-arranged, transparent timing for the sale
• Comprehensive disclosure of option grants and vesting schedules which clarifies potential future dilution and insider incentives
• Several stock options are fully vested and exercisable, indicating alignment of the executive with shareholder value

Negative

• Insider sold 3,173 shares at $42.50, reducing direct holdings to 76,127 shares
• Substantial outstanding option pool (hundreds of thousands of underlying shares) could lead to future dilution if exercised

Insights

Financial Analyst

TL;DR: Routine, disclosed sale under a 10b5-1 plan with substantial remaining option exposure; limited immediate market impact.

The reporting shows an OC-level insider executed a Rule 10b5-1 sale of 3,173 shares at $42.50, modestly reducing direct holdings to 76,127 shares. The filing lists significant option positions totaling over 400,000 shares exercisable or subject to vesting across multiple grants with exercise prices from $10.178 to $33.36, indicating continued equity alignment with company performance. These elements are standard insider activity and do not, by themselves, indicate change to corporate strategy or material financial condition.

Corporate Governance Expert

TL;DR: Properly documented insider sale and option grants; governance disclosure appears compliant and transparent.

The Form 4 documents an officer-level sale executed pursuant to a Rule 10b5-1 plan and describes vesting schedules and exercisability for multiple option awards. The filing includes statements that several options are fully vested and others vest over future anniversaries, providing investors clarity on potential future dilution and insider incentives. Filing includes an attorney-in-fact signature, consistent with procedural practice.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Burth Jonathan

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/29/2025		M		3,173	A	$10.178	79,300	D
Common Stock	09/29/2025		S(1)		3,173	D	$42.5	76,127	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178	09/29/2025		M			3,173	(2)	12/16/2029	Common Stock	3,173	$0.0	28,825	D
Non-Qualified Stock Option (right to buy)	$10.178							(3)	02/10/2030	Common Stock	222,950		222,950	D
Non-Qualified Stock Option (right to buy)	$10.178							(4)	01/11/2031	Common Stock	34,125		34,125	D
Non-Qualified Stock Option (right to buy)	$15							(5)	10/21/2031	Common Stock	58,043		58,043	D
Non-Qualified Stock Option (right to buy)	$15.36							(6)	08/15/2032	Common Stock	42,980		42,980	D
Non-Qualified Stock Option (right to buy)	$16.91							(7)	03/10/2033	Common Stock	14,205		14,205	D
Non-Qualified Stock Option (right to buy)	$26.18							(8)	03/04/2034	Common Stock	8,746		8,746	D
Non-Qualified Stock Option (right to buy)	$33.36							(9)	03/04/2035	Common Stock	13,218		13,218	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The stock option is fully vested and currently exercisable.

3. The stock option is fully vested and currently exercisable.

4. The stock option is fully vested and currently exercisable.

5. The stock option vests in four equal annual installments beginning on November 27, 2022.

6. The stock option vests in three equal annual installments beginning on August 15, 2025.

7. The stock option vests in four equal annual installments beginning on March 10, 2024.

8. The stock option vests in four equal annual installments beginning on March 4, 2025.

9. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

	By: Alison Klein, Attorney-in-Fact For: Jonathan Burth	10/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did COCO insider Jonathan Burth sell and at what price?

The filing shows 3,173 shares of COCO common stock were sold at $42.50 per share under a Rule 10b5-1 plan.

How did the sale affect Jonathan Burth's holdings?

After the transactions reported, the filing shows Burth's direct beneficial ownership was 76,127 shares.

What stock options does the reporting person hold?

The report lists multiple non-qualified stock options with exercise prices from $10.178 to $33.36, totaling over 400,000 underlying shares across grants.

Are any of the options immediately exercisable?

Yes. The filing states several stock options are fully vested and currently exercisable.

Was the sale part of a pre-arranged plan?

Yes. The filing explains the share sales were effected pursuant to a Rule 10b5-1 trading plan.